QVT Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

QVT Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,984,100	Closed	-$174M	–	55
2018 Q1	$174M	Buy	1,984,100 +489,100	+33%	+$44.7M	18.26%	1
2017 Q4	$127M	Sell	1,495,000 -2,255,000	-60%	-$189M	7.16%	3
2017 Q3	$325M	Sell	3,750,000 -250,000	-6%	-$20M	12.1%	3
2017 Q2	$309M	Sell	4,000,000 -1,829,700	-31%	-$130M	8.24%	3
2017 Q1	$404M	Sell	5,829,700 -3,076,700	-35%	-$207M	12.55%	3
2016 Q4	$527M	Buy	8,906,400 +4,124,600	+86%	+$255M	16.01%	2
2016 Q3	$317M	Buy	4,781,800 +526,800	+12%	+$32.6M	11.95%	2
2016 Q2	$230M	Sell	4,255,000 -1,345,000	-24%	-$73.7M	15.84%	1
2016 Q1	$289M	Buy	5,600,000 +7,500	+0.1%	+$390K	17.74%	1
2015 Q4	$393M	Sell	5,592,500 -902,500	-14%	-$61.6M	22.04%	1
2015 Q3	$404M	Sell	6,495,000 -1,125,000	-15%	-$88.7M	13.85%	2
2015 Q2	$641M	Buy	7,620,000 +3,720,000	+95%	+$289M	9.69%	3
2015 Q1	$293M	Buy	+3,900,000	New	+$272M	16.32%	1

Other funds holding XBI

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

QVT Financial's XBI Position: Q4 2018 in Review

QVT Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2018, closing a stake of 222,443 shares — an estimated $21.3M sold.

QVT Financial first reported a position in XBI in Q2 2015 and held it in 7 quarters. The position peaked at $66.4M in Q1 2018. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.

QVT Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2018 after selling out during the quarter.
QVT Financial sold 222,443 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $21.3M.
QVT Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 7 quarters.
QVT Financial's State Street SPDR S&P Biotech ETF position peaked at $66.4M in Q1 2018.
427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.

Based on QVT Financial's 13F filing for Q4 2018, filed 14 Feb 2019.